Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation

Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation

Objectives: This study aimed to develop a piperacillin population PK model for critically ill Brazil-ian patients and describe interethnic variation using an external validation. Methods: Plasma samples were obtained from 24 ICU patients during the fifth day of piperacillin treatment and assayed by...

Full description

Bibliographic Details
Main Authors: Cristina Sanches, Geisa C. S. Alves, Andras Farkas, Samuel Dutra da Silva, Whocely Victor de Castro, Farah Maria Drummond Chequer, Francisco Beraldi-Magalhães, Igor Rafael dos Santos Magalhães, André de Oliveira Baldoni, Mark D. Chatfield, Jeffrey Lipman, Jason A. Roberts, Suzanne L. Parker
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Antibiotics
Subjects:
piperacillin
pharmacokinetics
critically ill
ethnic group
antimicrobial
Online Access:https://www.mdpi.com/2079-6382/11/4/434

Internet

https://www.mdpi.com/2079-6382/11/4/434

Similar Items